| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wang,Jian-Hong | Chairman | 2.80% | |
| Wang,Jian-Rong | Vice Chairman | 4.17% | |
| Chen,Zhen-Zu | Director | 4.32% | |
| Lin,Wan-Wan | Director | 0.00% | |
| Chen,Zhao-Ji | Director | 0.03% | |
| Peter Dale Nickerson | Director | 0.59% | |
| Lv,Zong-Da | Director | 0.09% | |
| Chen,Shi-Rong | Director | 3.92% | |
| Zhong,Yi-Hua | Director | 0.00% | |
| Xiao,Cui-Hui | Independent Director | 0.00% | |
| Lv,You-Sheng | Independent Director | 0.00% | |
| Lin,Zhong-Yi | Independent Director | 0.00% | |
| Li,Xue-Cheng | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 20,722,823 | 87,487,470 | 85,767,264 |
| Operating cost | 16,347,342 | 67,674,019 | 67,991,313 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 4,375,481 | 19,813,451 | 17,775,951 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 4,375,481 | 19,813,451 | 17,775,951 |
| Operating expenses | 2,986,380 | 12,422,386 | 11,192,299 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 1,389,101 | 7,391,065 | 6,583,652 |
| Non-operating income and expenses | 264,566 | 1,190,981 | 497,427 |
| Net profit (loss) before tax | 1,653,667 | 8,582,046 | 7,081,079 |
| Income tax expense (benefits) | 457,380 | 2,316,489 | 1,635,142 |
| Net profit (loss) of ongoing business for the current period | 1,196,287 | 6,265,557 | 5,445,937 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 1,196,287 | 6,265,557 | 5,445,937 |
| Other comprehensive profit (loss), net | 356,025 | 2,165,363 | -48,148 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 1,552,312 | 8,430,920 | 5,397,789 |
| Net profit (loss) attributable to owners of parent company | 1,148,764 | 5,869,538 | 4,974,908 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 47,523 | 396,019 | 471,029 |
| Comprehensive profit (loss) attributable to owners of parent company | 1,479,108 | 7,930,644 | 4,953,248 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 73,204 | 500,276 | 444,541 |
| Basic earnings per share (yuan) | 1 | 5 | 5 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -417,313 | 8,217,928 | 7,300,048 |
| Net cash inflows (outflows) from investing activities | -712,168 | -2,973,357 | -4,340,847 |
| Net cash inflow (outflow) from financing activities | -271,996 | -4,257,359 | -4,495,952 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 67,688 | 294,489 | -177,889 |
| Increase (decrease) in cash and cash equivalents in the current period | -1,333,789 | 1,281,701 | -1,714,640 |
| Beginning balance of cash and cash equivalents | 5,140,543 | 3,858,842 | 5,573,482 |
| Ending balance of cash and cash equivalents | 3,806,754 | 5,140,543 | 3,858,842 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 24,746,739 | 24,885,697 | 22,605,747 |
| Non-current asset | 29,715,164 | 29,507,085 | 28,041,176 |
| Total asset | 54,461,903 | 54,392,782 | 50,646,923 |
| Current liability | 14,407,117 | 13,773,681 | 13,616,533 |
| Non-current liability | 9,936,737 | 11,790,219 | 11,975,559 |
| Total liability | 24,343,854 | 25,563,900 | 25,592,092 |
| share capital | 9,874,828 | 9,874,828 | 9,874,828 |
| Equity - secruity token | - | - | - |
| capital reserve | 49,085 | 49,085 | 53,750 |
| retained earning | 17,704,896 | 16,556,132 | 14,358,973 |
| Other equity | 690,350 | 360,006 | -1,127,303 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 28,319,159 | 26,840,051 | 23,160,248 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 1,798,890 | 1,988,831 | 1,894,583 |
| Total Equity | 30,118,049 | 28,828,882 | 25,054,831 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 28 | 27 | 23 |
